Back to search
End Stage Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which End Stage Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which End Stage Cancer trials you may qualify forThis phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral…
The use of a novel topical mucosa composition (XCM-OM118) comprising 2-(trimethylazaniumyl) acetate; (2R,3R,4S)-pentane-1,2,3,4,5-pentol; Hexadecanoic acid; (9Z…
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlima…
The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer a…
This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in…
This phase II trial studies how to improve the usage of Lu 177 vipivotide tetraxetan (177Lu-prostate-specific membrane antigen \[PSMA\]-617) for treating patien…
This phase II trial studies the effect of rituximab, lenalidomide, acalabrutinib, tafasitamab alone and in combination with chemotherapy in treating patients wi…
The study aims to find out if community health worker (CHW) support will improve palliative care outcomes in African American patients with advanced cancer, by…